Go to Top

Investors Launch Class Action Against Valeant Pharmaceuticals in British Columbia:Lawsuit seeks compensation, citing oppressive conduct and misrepresentations

TORONTO, November 17, 2015 – Law firm Investigation Counsel Professional Corporation has commenced a class action in Vancouver on behalf of investors of Valeant Pharmaceuticals International Inc. (TSX:  VRX-T), which is incorporated under the laws of British Columbia.  The suit alleges oppression and securities violations by the company and certain of its directors and officers.

The claim arises from allegedly unlawful and improper business practices engaged in by Valeant and its agents to boost sales of the company’s expensive brand name drugs.  Between September 28, 2015, and November 5, 2015, the price of the company’s shares dropped over 60%, a market loss of over $50 billion.  The price of the company’s bonds also fell significantly during this period. These steep declines followed revelations of U.S. government investigations into Valeant’s pricing and business practices and disclosure of the company’s interest in a network of captive pharmacies.  It is alleged that the company’s reputation has been damaged and its future business prospects have been severely prejudiced.  Valeant’s investors have suffered substantial harm as a result.

The lawsuit has been brought on behalf of investors who purchased shares or bonds of Valeant between February 28, 2013, and October 21, 2015.

September 9, 2019

A proposed partial settlement has been reached with PricewaterhouseCoopers LLP on behalf of certain investors in the common shares and notes of Valeant Pharmaceuticals International Inc. A hearing to determine if the settlement will be approved will take place on November 11, 2019.  For more details or to opt out of the proposed settlement, please see the below documents or contact John Archibald at 416-637-3150 or jarchibald@investigationcounsel.com.

 

Settlement Long Form Notice and Opt Out Form (English)

Settlement Long Form Notice and Opt Out Form (French)

 


Valeant Pharmaceuticals Contact Form

This Is Not A Claim Form

You are not obligated to fill in this form and, if you choose to do so, you are not retaining Investigation Counsel P.C. to act on your behalf.  Your personal information will not be disclosed to a third party without your consent or unless it is required by law.

  • Number and Series Of Valeant Notes Acquired Between February 28,2013 and October 21, 2015
  • Number and Series of Valeant Notes Held as of October 21, 2015

 

Call Now Button